Associations - KRAS Q61H

BIOMARKER:

KRAS Q61H

Entrez ID:

Related biomarkers:

‹

›

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

KRAS Q61H KRAS Q61H	Hepatocellular Cancer HCC	sorafenib + BAY86-9766 Sensitive: C3 – Early Trials sorafenib + BAY86-9766 Sensitive : C3
KRAS Q61H KRAS Q61H	Colorectal Cancer CRC	trametinib + panitumumab Resistant: C3 – Early Trials trametinib + panitumumab Resistant : C3
KRAS Q61H KRAS Q61H	Colorectal Cancer CRC	cetuximab Resistant: D – Preclinical cetuximab Resistant : D
KRAS Q61H KRAS Q61H	Non Small Cell Lung Cancer NSCLC	P1446A-05 Sensitive: D – Preclinical P1446A-05 Sensitive : D